WallStreetZenWallStreetZen

NASDAQ: EYPT
Eyepoint Pharmaceuticals Inc Stock Ownership - Who owns Eyepoint Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Eyepoint Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Nancy LurkerDirector2025-11-28500$14.95
$7.48kSell
Nancy LurkerDirector2025-11-26200$14.95
$2.99kSell
Ramiro RibeiroChief Medical Officer2025-11-112,722$11.61
$31.60kSell
Jay S. DukerPresident and CEO2025-07-107,688$11.06
$85.03kSell
Jay S. DukerPresident and CEO2025-06-2356,665$8.21
$465.22kSell
George ElstonChief Financial Officer2025-05-252,202$5.68
$12.51kSell
Karen L. ZaderejDirector2025-05-195,000$5.99
$29.95kBuy
Karen L. ZaderejDirector2025-05-165,000$5.81
$29.05kBuy
Karen L. ZaderejDirector2025-05-155,000$5.47
$27.35kBuy
Karen L. ZaderejDirector2025-05-145,000$5.42
$27.10kBuy

1 of 2

EYPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EYPT insiders and whales buy or sell their stock.

EYPT Shareholders

What type of owners hold Eyepoint Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ew Healthcare Partners LP105.45%87,298,833$1.24BInsider
Pfizer Inc89.97%74,483,748$1.06BInsider
Ronald W. Eastman20.79%17,212,648$245.45MInsider
Cormorant Asset Management LP14.32%11,855,943$169.07MInsider
Cormorant Asset Management LP10.06%8,325,000$118.71MInstitution
Suvretta Capital Management LLC7.48%6,192,715$88.31MInstitution
Adage Capital Partners GP LLC6.72%5,559,782$79.28MInstitution
Adage Capital Management LP6.23%5,156,299$73.53MInsider
Blackrock Inc6.00%4,964,526$70.79MInstitution
Federated Hermes Inc5.33%4,416,332$62.98MInstitution

1 of 3

EYPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EYPT25.94%74.06%Net SellingNet Selling
ANAB42.69%57.31%Net BuyingNet Selling
URGN81.41%18.59%Net SellingNet Selling
XNCR72.07%27.93%Net Selling
TYRA62.03%37.97%Net BuyingNet Selling
View Top Biotech Stocks

Eyepoint Pharmaceuticals Stock Ownership FAQ

Who owns Eyepoint Pharmaceuticals?

Eyepoint Pharmaceuticals (NASDAQ: EYPT) is owned by 83.79% institutional shareholders, 239.28% Eyepoint Pharmaceuticals insiders, and 0.00% retail investors. Ew Healthcare Partners LP is the largest individual Eyepoint Pharmaceuticals shareholder, owning 87.30M shares representing 105.45% of the company. Ew Healthcare Partners LP's Eyepoint Pharmaceuticals shares are currently valued at $1.20B.

If you're new to stock investing, here's how to buy Eyepoint Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.